BRPI0920502A2 - compostos cicloundecadepsipeptídeos e seu uso como medicamento - Google Patents

compostos cicloundecadepsipeptídeos e seu uso como medicamento

Info

Publication number
BRPI0920502A2
BRPI0920502A2 BRPI0920502A BRPI0920502A BRPI0920502A2 BR PI0920502 A2 BRPI0920502 A2 BR PI0920502A2 BR PI0920502 A BRPI0920502 A BR PI0920502A BR PI0920502 A BRPI0920502 A BR PI0920502A BR PI0920502 A2 BRPI0920502 A2 BR PI0920502A2
Authority
BR
Brazil
Prior art keywords
medicines
cycloundecadepsipeptide
compounds
cycloundecadepsipeptide compounds
Prior art date
Application number
BRPI0920502A
Other languages
English (en)
Inventor
Grégoire Vuagniaux
Laura Novaroli Zanolari
Manfred Mutter
Olivier Turpin
Patrick Garrouste
Rafael Crabbé
Robert Lysek
Roland Wenger
Valérie Nicolas
Original Assignee
Debio Rech Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debio Rech Pharma Sa filed Critical Debio Rech Pharma Sa
Publication of BRPI0920502A2 publication Critical patent/BRPI0920502A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0920502A 2008-11-06 2009-11-06 compostos cicloundecadepsipeptídeos e seu uso como medicamento BRPI0920502A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2008002982 2008-11-06
PCT/IB2009/007361 WO2010052559A1 (en) 2008-11-06 2009-11-06 Cycloundecadepsipeptide compounds and use of said compounds as a medicament

Publications (1)

Publication Number Publication Date
BRPI0920502A2 true BRPI0920502A2 (pt) 2015-12-22

Family

ID=40795063

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0920502A BRPI0920502A2 (pt) 2008-11-06 2009-11-06 compostos cicloundecadepsipeptídeos e seu uso como medicamento

Country Status (21)

Country Link
US (1) US8501683B2 (pt)
EP (1) EP2355837A1 (pt)
JP (1) JP5758806B2 (pt)
KR (1) KR20110093858A (pt)
CN (1) CN102202679B (pt)
AU (1) AU2009312535B2 (pt)
BR (1) BRPI0920502A2 (pt)
CA (1) CA2741829A1 (pt)
CO (1) CO6361943A2 (pt)
CR (1) CR20110284A (pt)
EA (1) EA020896B1 (pt)
EC (1) ECSP11011101A (pt)
HK (1) HK1167592A1 (pt)
IL (1) IL212672A (pt)
MA (1) MA32841B1 (pt)
MX (1) MX2011004881A (pt)
NZ (1) NZ593204A (pt)
TN (1) TN2011000204A1 (pt)
UA (1) UA102414C2 (pt)
WO (1) WO2010052559A1 (pt)
ZA (1) ZA201103752B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
WO2012145426A1 (en) 2011-04-18 2012-10-26 The Trustees Of Columbia University In The City Of New York Methods to treat cancer using cyclosporine and cyclosporine derivatives
WO2013169616A1 (en) * 2012-05-07 2013-11-14 Novartis Ag Pharmacokinetic modulation with alisporivir
AR090964A1 (es) 2012-05-09 2014-12-17 Novartis Ag Proceso para la elaboracion de undecapeptidos ciclicos
CN104603146B (zh) * 2012-09-29 2018-01-02 诺华股份有限公司 环肽类化合物及其作为药物的用途
GB201217560D0 (en) * 2012-10-02 2012-11-14 Mitopharm Ltd Novel cyclic depsipeptide compounds and their uses
GB201222455D0 (en) * 2012-12-13 2013-01-30 Perioc Ltd Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
KR20200007863A (ko) 2017-05-12 2020-01-22 추가이 세이야쿠 가부시키가이샤 환상 유기 화합물의 제조 방법
RU2716706C1 (ru) * 2019-12-04 2020-03-16 Федеральное государственное бюджетное учреждение "Национальный исследовательский центр "Курчатовский институт" Способ получения полимерсодержащей композиции силибина

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE110784T1 (de) * 1987-06-19 1994-09-15 Sandoz Ag Zyklische peptolide.
KR100695611B1 (ko) * 2001-05-17 2007-03-14 주식회사 엘지생활건강 [감마 히드록시 엔-메틸 엘-루신4] 사이클로스포린유도체를 유효성분으로 하는 모발 성장 촉진제
GB0320638D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
ATE490778T1 (de) 2004-10-01 2010-12-15 Debiopharm Sa Verwendung von äd-mealaü3-äetvalü4-ciclosporin zur behandlung von hepatitis-c-infektion

Also Published As

Publication number Publication date
CO6361943A2 (es) 2012-01-20
MX2011004881A (es) 2011-08-12
CN102202679B (zh) 2014-05-07
ECSP11011101A (es) 2011-10-31
US20110212057A1 (en) 2011-09-01
AU2009312535B2 (en) 2015-03-26
JP2012507576A (ja) 2012-03-29
ZA201103752B (en) 2012-03-28
EA201170605A1 (ru) 2011-12-30
IL212672A0 (en) 2011-07-31
US8501683B2 (en) 2013-08-06
EP2355837A1 (en) 2011-08-17
AU2009312535A1 (en) 2011-06-23
WO2010052559A8 (en) 2011-06-09
UA102414C2 (ru) 2013-07-10
CR20110284A (es) 2011-09-19
EA020896B1 (ru) 2015-02-27
NZ593204A (en) 2013-02-22
MA32841B1 (fr) 2011-11-01
JP5758806B2 (ja) 2015-08-05
WO2010052559A1 (en) 2010-05-14
IL212672A (en) 2016-10-31
CA2741829A1 (en) 2010-05-14
KR20110093858A (ko) 2011-08-18
TN2011000204A1 (en) 2012-12-17
CN102202679A (zh) 2011-09-28
HK1167592A1 (en) 2012-12-07

Similar Documents

Publication Publication Date Title
BRPI0920448A2 (pt) compostos spiro-oxindol e seu uso como agentes terapêuticos
BRPI1010533A2 (pt) tetrahidroazolopirazinas sulfoniladas e seu uso como medicamentos
BRPI0913885A8 (pt) tiadiazoliloxifenilamidinas e seu uso como fungicidas
BRPI0914536A2 (pt) tiadiazoliloxifenilamidinas e o uso destas como fungicidas
SMT201600258B (it) Composto indolico e suo uso farmaceutico
BRPI0817881A2 (pt) Compostos orgânicos e seus usos
BR112013016030A2 (pt) compostos e seu uso como inibidores de bace
BRPI1008082A2 (pt) Isotiazoliloxifenilamisinas e seu emprego como fungicidas
BRPI1016150A2 (pt) compostos heterocíclicos e seus usos.
BRPI0912431A2 (pt) Combinações de substâncias ativas sinergísticas
BR112012000660A2 (pt) compostos heterociclos e seus usos
BRPI1012533A2 (pt) composto de piradazinona e uso do mesmo
BRPI0922845A2 (pt) pirazol-4-n-alcoxicarboxamidas como microbiocidas
BRPI0914895A2 (pt) artigo absorvente
BRPI0918372A2 (pt) artigo absorvente
BRPI0820241A2 (pt) artigo absorvente
BRPI0821175A2 (pt) artigo absorvente
BRPI0814231A2 (pt) Derivados de pleuromutilina e seu uso como antimicrobianos
BRPI0920502A2 (pt) compostos cicloundecadepsipeptídeos e seu uso como medicamento
BRPI1010621A2 (pt) derivado de imidazoquinolinonas, sua composição farmacêutica e seu uso
BRPI0919810A2 (pt) compostos heterocíclicos contendo nitrogênio, sua preparação e seu uso como medicamentos antibacterianos
BR112012008044A2 (pt) pteridinas e seu uso como agroquímicos
BRPI1007494A2 (pt) composto e uso do mesmo
BRPI0816372A2 (pt) Ácidos 6-fenilnicotínicos substituídos e seu uso
BRPI0808846A2 (pt) fenoxifenilamidinas 3-substituídas e seu uso como fungicidas

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2487 DE 04-09-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.